Published in J Natl Cancer Inst on May 04, 1994
Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta. Genes Dev (2004) 2.94
Tumour markers of prognosis in colorectal cancer. Br J Cancer (1999) 1.68
p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol (1995) 1.32
Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. Proc Natl Acad Sci U S A (1996) 1.31
BK virus as a cofactor in the etiology of prostate cancer in its early stages. J Virol (2007) 1.29
Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. Am J Pathol (1996) 1.24
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer (2000) 1.11
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09
Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature. Int J Colorectal Dis (2003) 1.07
Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation. J Clin Pathol (2001) 1.06
Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis. Hepatology (2010) 1.03
Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy. World J Gastroenterol (2008) 1.02
p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. Br J Cancer (2005) 0.93
Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer. Br J Cancer (1998) 0.91
Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer (1995) 0.90
Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer (1996) 0.87
Prognostic markers for colorectal cancer: expression of P53 and BCL2. World J Surg (1997) 0.87
Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br J Cancer (1996) 0.86
Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells. Oncogene (2009) 0.85
Irinotecan therapy and molecular targets in colorectal cancer: a systemic review. World J Gastroenterol (2009) 0.84
Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer (1998) 0.82
Is there a genetic signature for liver metastasis in colorectal cancer? World J Gastroenterol (2007) 0.80
Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation. Br J Cancer (1997) 0.80
Midgut Carcinoids and Solid Carcinomas of the Intestine: Differences in Endocrine Markers and p53 Mutations. Endocr Pathol (1996) 0.80
p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group. Br J Cancer (1995) 0.80
Nuclear to cytoplasmic shift of p33(ING1b) protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables. J Cancer Res Clin Oncol (2007) 0.79
Loss of HSF1 results in defective radiation-induced G(2) arrest and DNA repair. Radiat Res (2011) 0.78
Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study. J Exp Clin Cancer Res (2010) 0.76
Prognostic significance of p53-expression in colorectal carcinoma as measured by a luminometric immunoassay. Ger Med Sci (2010) 0.75
Biological indices in the assessment of breast cancer. Clin Mol Pathol (1995) 0.75
p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis. Cell Death Differ (2017) 0.75
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet (1997) 6.99
Controlled trial of early mobilisation and discharge from hospital in uncomplicated myocardial infarction. Lancet (1971) 6.52
Geometric diffusions as a tool for harmonic analysis and structure definition of data: diffusion maps. Proc Natl Acad Sci U S A (2005) 6.24
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol (2002) 4.32
Role of experience and oscillations in transforming a rate code into a temporal code. Nature (2002) 3.86
Properties of the fusion pore that forms during exocytosis of a mast cell secretory vesicle. Neuron (1990) 3.07
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer (1996) 3.07
Geometric diffusions as a tool for harmonic analysis and structure definition of data: multiscale methods. Proc Natl Acad Sci U S A (2005) 3.00
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst (1999) 2.90
CDC25 phosphatases as potential human oncogenes. Science (1995) 2.84
Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut (2009) 2.75
Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol (1992) 2.72
bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol (1997) 2.66
The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res (1996) 2.57
Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med (1972) 2.50
A low affinity Ca2+ receptor controls the final steps in peptide secretion from pituitary melanotrophs. Neuron (1993) 2.47
The 5-year results of a clinical trial comparing a glass polyalkenoate (ionomer) cement restoration with an amalgam restoration. Br Dent J (1991) 2.43
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol (2001) 2.42
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol (2001) 2.19
The use of a reinforced glass-ionomer cermet for the restoration of primary molars: a clinical trial. Br Dent J (1995) 2.13
A triggered mechanism retrieves membrane in seconds after Ca(2+)-stimulated exocytosis in single pituitary cells. J Cell Biol (1994) 2.12
Patterns of integrin common chain beta 1 and collagen IV immunoreactivity in hepatocellular carcinoma. Correlations with tumour growth rate, grade and size. J Pathol (1993) 2.12
Adult Dental Health Survey 2009: common oral health conditions and their impact on the population. Br Dent J (2012) 2.12
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Ann Oncol (2010) 2.02
Genetic evidence and new morphometric data as essential tools to identify the Patagonian seahorse Hippocampus patagonicus (Pisces, Syngnathidae). J Fish Biol (2014) 1.97
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
Adult Dental Health Survey 2009: transformations in British oral health 1968-2009. Br Dent J (2012) 1.90
Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest (1989) 1.85
Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature (1991) 1.83
The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology (1999) 1.74
Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol (2000) 1.73
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol (2012) 1.69
Outcome of special types of luminal breast cancer. Ann Oncol (2011) 1.67
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol (1993) 1.64
Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest (1997) 1.63
Obstruction after ileal pouch-anal anastomosis: a preventable complication? Dis Colon Rectum (1993) 1.62
Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy (2001) 1.62
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Ann Oncol (2005) 1.60
Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med (2001) 1.57
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy. Chest (2001) 1.57
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer (2003) 1.55
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol (2007) 1.54
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med (1998) 1.53
Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol (1996) 1.52
The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer (1994) 1.51
Should liver metastases of breast cancer be biopsied to improve treatment choice? Ann Oncol (2011) 1.50
Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma. Chest (1999) 1.48
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol (2010) 1.47
Adult Dental Health Survey 2009: relationships between dental attendance patterns, oral health behaviour and the current barriers to dental care. Br Dent J (2013) 1.47
Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis (1978) 1.46
Fissure sealants: a critique of their cost-effectiveness. Community Dent Oral Epidemiol (1989) 1.46
Recombinant dengue virus type 1 NS3 protein exhibits specific viral RNA binding and NTPase activity regulated by the NS5 protein. Virology (1998) 1.46
Quality indicators in breast cancer care. Eur J Cancer (2010) 1.46
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol (2014) 1.45
The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol (2001) 1.45
Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens. Clin Exp Immunol (1976) 1.42
Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganese. J Vasc Res (1993) 1.41
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat (2009) 1.41
Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res (1995) 1.39
Immunoreactivity for latent membrane protein 1 of Epstein-Barr virus in nevi and melanomas is not related to the viral infection. Virchows Arch (2000) 1.39
Methodological issues involved in sampling a population of the elderly for a dental survey. Community Dent Health (1995) 1.39
Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol (1980) 1.38
Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care (2003) 1.38
Laparoscopic colectomy: indications for conversion to laparotomy. Arch Surg (1999) 1.35
The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med (1993) 1.32
p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol (1995) 1.32
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study. Oral Oncol (2008) 1.31
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol (2006) 1.29
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 2: dentofacial outcomes and patient satisfaction. Cleft Palate Craniofac J (2001) 1.29
Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene (2007) 1.28
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation (1987) 1.27
Long-term results of the ileoanal pouch procedure. Arch Surg (1993) 1.26
Surgical management of Crohn's disease involving the duodenum. Am J Surg (1984) 1.26
Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol (1993) 1.25
Syndrome of inappropriate antidiuretic hormone with imipramine. Drug Intell Clin Pharm (1986) 1.23
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol (2008) 1.23
Addition of parenteral cefoxitin to regimen of oral antibiotics for elective colorectal operations. A randomized prospective study. Ann Surg (1990) 1.23
S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry. Hum Pathol (1987) 1.22
Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg (1999) 1.22
Maternal-fetal transmission of Pneumocystis carinii in human immunodeficiency virus infection. N Engl J Med (1995) 1.22
Pulmonary epithelial-myoepithelial tumor of unproven malignant potential: report of a case and review of the literature. Mod Pathol (2001) 1.22
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol (2001) 1.21
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 3: speech outcomes. Cleft Palate Craniofac J (2001) 1.21
bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol (1995) 1.21
Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer (1996) 1.21
Enamel opacities: prevalence, classifications and aetiological considerations. J Dent (1978) 1.20